fbpx
  Previous   Next
HomeHealthGlenmark Launches Nasal Spray To Treat Adult Covid-19 Patients

Glenmark Launches Nasal Spray To Treat Adult Covid-19 Patients

Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research and Development Corp on Wednesday, 9 February, announced the launch of nasal spray to treat adult COVID-19 patients.

According to Glenmark, the nitric oxide nasal spray (NONS) will be sold under the brand FabiSpray in India for the treatment of adult patients with COVID-19 who have a high risk of progression of the disease.

Glenmark earlier received manufacturing and marketing approval from the Drugs Controller General of India (DCGI) for NONS as part of the accelerated approval process.

In July 2021, Glenmark entered into an exclusive long term strategic partnership with Canadian biotech firm SaNOtize, to manufacture, market and distribute its breakthrough NONS for COVID-19 treatment in India and other Asian markets including Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor-Leste and Vietnam.

More News

Smartphone Use And An Increase In Social Isolation Point To Decline In Mental Health of Young Adults: Report

If you are a young adult and spend a lot of time on your smartphone that it may cause a rapid decline in your...

Inflation Is One of The Top Issues In World Wide: Ipsos

Inflation has shot up the rankings to be the number one global concern in April, according to Ipsos. In March, Inflation made the top...

Two Years After Infection, Half of People Hospitalised With Covid Have At Least One Symptom: Study

Two years after getting infected with COVID-19, half of people hospitalised with the infection have at least one symptom, a follow-up study by the...

RELATED NEWS

Two Years After Infection, Half of People Hospitalised With Covid Have At Least One Symptom: Study

Two years after getting infected with COVID-19, half of people hospitalised with the infection have at least one symptom, a follow-up study by the...

89% of Children Between 6-23 Months Don’t Receive Minimum Acceptable Diet: NFHS Report

National Family Health Survey (NFHS-5) has found that 89 per cent of children between the formative ages of 6-23 months do not receive a...

Those Going Abroad Can Take Precaution Dose Before 9 Months: NTAGI

The National Technical Advisory Group on Immunisation (NTAGI) has recommended allowing the administration of the precautionary dose of Covid vaccine before nine months for...